• $675,854.00
    Market Cap
  • -59.56%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.01
$0.01
$0.01
1-Year Range
$0.009
$0.03
$0.01
Latest Close$0.01
Change
+$0.003 (+19.71%)
Volume300
Market Cap$675,854.00
Shares Outstanding49.3M
P/E (TTM)-4.89
Diluted EPS (TTM)-$0.003
Enterprise Value$3.1M

Information as of 05/26/2026

Company Profile

NovelStem International Corp.
https://www.novelstem.com
$675,854.00
Market Cap
-$132,469.00
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
2255 Glades Road, Boca Raton, FL, United States, 33431
410 598 9024

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Key Executives

  • Christine Jenkins
  • David Collins
  • Jan H. Loeb
  • Mitchell Rubenstein

Current Ownership Distribution

  • Other49.3M (99.95%)
  • Institutions25,000 (0.05%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)